featured
Risk for Recurrence of GIST After Adjuvant Imatinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib
Cancer 2014 Apr 15;[EPub Ahead of Print], H Joensuu, M Eriksson, KS Hall, JT Hartmann, D Pink, J Schütte, G Ramadori, P Hohenberger, J Duyster, SE Al-Batran, M Schlemmer, S Bauer, E Wardelmann, M Sarlomo-Rikala, B Nilsson, H Sihto, KV Ballman, M Leinonen, RP Dematteo, P ReichardtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.